Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= pazopanib
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(8)
+
-
Availability
Open access
(3)
+
-
Metadata Only
(5)
+
-
Creation Date
2021
(3)
+
-
2015
(2)
+
-
2019
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(8)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(8)
+
-
Topic
pazopanib
(8)
+
-
pharmacokinetics
(5)
+
-
Sarcoma
(2)
+
-
TDM
(2)
+
-
anthracycline
(2)
+
-
soft tissue
(2)
+
-
Show more
Author
Gelderblom, H.
(6)
+
-
Erp, N.P. van
(5)
+
-
Desar, I.M.E.
(3)
+
-
Graaf, W.T.A. van der
(3)
+
-
Baldi, G.G.
(2)
+
-
Benjamin, R.S.
(2)
+
-
Burger, D.M.
(2)
+
-
Casali, P.G.
(2)
+
-
Duffaud, F.
(2)
+
-
Fedenko, A.
(2)
+
-
Frezza, A.M.
(2)
+
-
Guchelaar, H.J.
(2)
+
-
Hartigh, J. den
(2)
+
-
Herpen, C.M.L. van
(2)
+
-
Jones, R.L.
(2)
+
-
Kawai, A.
(2)
+
-
Koenen, A.M.
(2)
+
-
Mariani, L.
(2)
+
-
Ravi, V.
(2)
+
-
Stacchiotti, S.
(2)
+
-
Steeghs, N.
(2)
+
-
Teterycz, P.
(2)
+
-
Vincenzi, B.
(2)
+
-
Vullo, S. lo
(2)
+
-
Wit, D. de
(2)
+
-
Show more
Language
en
(8)
+
-
Search results
(1 - 8 of 8)
show grid
show list
save search
Revision of: a phase II study on the neo-adjuvant combination of pazopanib and radiotherapy in patients with high-risk, localized soft tissue sarcoma
Systemic therapies in advanced epithelioid haemangioendothelioma: a retrospective international case series from the World Sarcoma Network and a review of literature
The impact of a 1-hour time interval between pazopanib and subsequent intake of gastric acid suppressants on pazopanib exposure
Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma Network
Early Metabolic Response as a Predictor of Treatment Outcome in Patients With Metastatic Soft Tissue Sarcomas
Optimizing the dose in cancer patients treated with imatinib, sunitinib and pazopanib
Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Pazopanib
Therapeutic Drug Monitoring to Individualize the Dosing of Pazopanib: A Pharmacokinetic Feasibility Study